Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Clinical trial NCT02555397 · COMPLETED

Trial details

NCT number: NCT02555397
Sponsor: Henry Ford Health System
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2015-08-01
Primary completion: 2019-06-16
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.